semaglutide side effects skin rash Semaglutide-Induced Atypical Pustular Drug Eruption: A Case Report rash from tirzepatide injection Understanding

Semaglutide is administered as a once-weekly subcutaneous injection

Glucagon-like peptide-1 (GLP-1) receptor agonists were touted as breakthrough drugsin 2023 and their popularity has soared since. More than 4 million items of tirzepatide and semaglutide were dispensed on the NHS in England in 2025/20261, while around2.5 million people each monthaccessed GLP-1s privately at the end of 2025, according to James Kingsland, chair of []

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, others are continuing and pushing regulatory boundaries.

Recent Findings GLP-1 RAs effectively induce weight loss

Chronic spontaneous urticaria (CSU) is a mast cell-driven disease that affects approximately 1% of the population